Pregnancy And Congestion - Better
The Physiology and Management of Nasal Congestion in Pregnancy: A Review of "Rhinitis of Pregnancy"
| Medication Class | Examples | Safety Profile | Recommendation | | :--- | :--- | :--- | :--- | | | Budesonide (Pregnancy Cat B), Fluticasone (Cat C) | Minimal systemic absorption; budesonide has most reassuring safety data. | First-line pharmacotherapy for moderate-severe ROP. | | Intranasal Antihistamines | Azelastine (Cat C) | Limited systemic absorption; preferred over oral antihistamines. | Second-line, especially if allergic component suspected. | | Oral Antihistamines (non-sedating) | Loratadine, Cetirizine (Cat B) | Large post-marketing studies show no increased teratogenic risk. | Second-line for those with concurrent allergic rhinitis. | | Intranasal Cromolyn | Cromolyn sodium (Cat B) | Extremely safe, but requires frequent dosing (4-6x/day). | Third-line or adjunctive. | | Topical Decongestants | Oxymetazoline (Cat C) | Avoid prolonged use (>3 days) due to rhinitis medicamentosa; short-term use (1-2 days) only for severe obstruction. | Rescue only ; not for routine management. | | Oral Decongestants | Pseudoephedrine (Cat C) | Avoid in first trimester (theoretical risk of gastroschisis with first-trimester exposure); contraindicated with hypertension or preeclampsia. | Avoid unless severe and under physician guidance. | pregnancy and congestion
Management of ROP emphasizes safety for both mother and fetus. The FDA pregnancy risk categories (A, B, C, D, X) provide guidance, though many drugs lack rigorous pregnancy trials. The Physiology and Management of Nasal Congestion in
Most INCS, saline, and intranasal antihistamines are compatible with breastfeeding (Lactation Risk Category L1-L2). Pseudoephedrine can reduce milk supply and should be avoided. Oxymetazoline is considered compatible for short-term use. | Second-line, especially if allergic component suspected
Nasal congestion is a common yet frequently underappreciated symptom during pregnancy. While often attributed to coincidental viral infections or allergies, a distinct entity known as "rhinitis of pregnancy" (ROP) exists, characterized by nasal obstruction in the absence of other infectious or allergic triggers. This paper reviews the epidemiological evidence, explores the multifactorial pathophysiology driven by hormonal fluctuations (estrogen, progesterone, and placental growth hormone) and increased plasma volume, discusses the clinical presentation and differential diagnosis, and provides evidence-based guidelines for safe management during gestation and lactation.
